openPR Logo
Press release

Deadline on January 14th in Lawsuit for Investors in Lipocine Inc. (NASDAQ: LPCN) coming up

01-14-2020 04:09 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on January 14, 2020 in the lawsuit for certain investors in Lipocine Inc. (NASDAQ: LPCN).

A Deadline is coming up on January 14, 2020 in the lawsuit for certain investors in Lipocine Inc. (NASDAQ: LPCN).

The Shareholders Foundation announced that a deadline is coming up on January 14, 2020 in the lawsuit filed for certain investors of Lipocine Inc. (NASDAQ: LPCN) over alleged securities laws violations by Lipocine Inc.

Investors who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and there are strict and short deadlines running. Deadline: January 14, 2020. NASDAQ: LPCN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the District of Utah the plaintiff alleges on behalf of purchasers of Lipocine Inc. (NASDAQ: LPCN) common shares between March 27, 2019, and November 8, 2019, that the defendants violated Federal Securities Laws.

More specifically, the plaintiff claims that between March 27, 2019, and November 8, 2019, the defendants made false and/or misleading statements and/or failed to disclose that the results from Lipocine’s clinical studies of TLANDO were insufficient to demonstrate the drug’s efficacy, that accordingly, Lipocine’s third NDA for TLANDO was highly likely to be found deficient by the FDA, and that as a result, the Company’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on January 14th in Lawsuit for Investors in Lipocine Inc. (NASDAQ: LPCN) coming up here

News-ID: 1896126 • Views: 296

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in shares of Waitr Holdings Inc. …
Certain directors of Waitr Holdings Inc are under investigation over potential breaches of fiduciary duties. Investors who are current long term investors in Waitr Holdings Inc. (NASDAQ: WTRH) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: WTRH stocks follows a lawsuit filed against Waitr Holdings Inc. over alleged
Investigation announced for Investors in Synacor, Inc. (NASDAQ: SYNC) over poten …
An investigation was announced concerning whether the takeover of Synacor, Inc. is unfair to NASDAQ: SYNC stockholders. Investors who purchased shares of Synacor, Inc. (NASDAQ: SYNC) and currently hold any of those NASDAQ: SYNC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Synacor, Inc. breached their fiduciary duties owed
Investigation announced for Investors in shares of Boral Limited (OTC: BOALY)
An investigation was announced concerning possible securities laws by Boral Limited in connection with certain financial statements. Investors who purchased shares of Boral Limited (OTC: BOALY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Boral Limited regarding its business, its prospects and its operations were materially false and misleading
Investigation announced for Investors in shares of Airbus SE (EADSY)
Airbus SE is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of Airbus SE (EADSY), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Airbus SE (EADSY regarding its business, its prospects and its operations were materially false and misleading at

All 5 Releases


More Releases for Lipocine

Trending Report : Male Hypogonadism Market Is Estimated To Reach $3,350 Million …
Male hypogonadism is a condition in which the body does not produce enough testosterone - a hormone that plays a key role in male growth and development during puberty - or has poor sperm production capacity or both .Male Hypogonadism Market Is Estimated To Reach $3,233 Million From $2,594 Million And Is Supported By a CAGR Of 3% During The Forecast Period Get Sample @ https://www.researchreportsinc.com/sample-request?id=31794 List of Key Players
Future of Female Contraceptive Products Market – A comprehensive study by Key …
MarketResearchNest.com adds “Global Female Contraceptive Products Industry Market Research Report” new report to its research database. The report spread across 103 pages with multiple tables and figures in it. This report studies the Female Contraceptive Products market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers.
New Report on : Global Topical Contraceptive Market 2017-2021 ; Analysis and Key …
Researchmoz added Most up-to-date research on "Global Topical Contraceptive Market 2017-2021" to its huge collection of research reports. About Topical Contraceptive Topical contraceptives are contraceptive patches that release hormones, estrogen, and progestin to prevent pregnancies. They work in a similar manner as oral contraceptives. Various temporary and permanent contraceptive methods and devices for women are available in the market. Permanent methods such as sterilization are considered the most effective as they
Global Premature Labor Treatment Market Size 2018-2023 ObsEva, Lipocine, AMAG Ph …
A market study "Global Premature Labor Treatment Market" examines the performance of the Premature Labor Treatment market 2018. It encloses an in-depth Research of the Premature Labor Treatment market state and the competitive landscape globally. This report analyzes the potential of Premature Labor Treatment market in the present and the future prospects from various angles in detail. The Global Premature Labor Treatment Market 2018 report includes Premature Labor Treatment market Revenue,
At a CAGR of 2%, Global Topical Contraceptive Market to rise over Forecast perio …
Topical contraceptives are contraceptive patches that release hormones, estrogen, and progestin to prevent pregnancies. They work in a similar manner as oral contraceptives. Various temporary and permanent contraceptive methods and devices for women are available in the market. Permanent methods such as sterilization are considered the most effective as they eliminate the chances of pregnancy. The global topical contraceptive market to grow at a CAGR of 2% during the period 2017-2021.
Global Womens Health Market 2016-2020 - Allergan, Bayer HealthCare, Merck, Pfize …
Womens health refers to the overall well-being experienced by women this includes physical, mental, and social well-being. It deals with the diagnosis and treatment of various diseases and conditions that affect women such as HIV/AIDS, endometriosis, infertility, polycystic ovary syndrome, postmenopausal osteoporosis, and cancer (primarily ovarian and breast cancer). It also includes issues other than the biological conditions, like gender inequality (women are sometimes not able to afford medical treatments)